Oversight of No Surprises Act implementation; clinician behavioral health and well-being, including funding of grant programs authorized by the Dr. Lorna Breen Provider Protection Act; S.3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Inflationary adjustment for physician fee schedule (H.R. 2474, Strengthening Medicare for Patients and Providers Act); Reduce proposed CY2024 cut to Medicare Physician Fee Schedule conversion factor by eliminating the proposed G2211 add-on code; Reduce or eliminate proposed cut to CY2024 Medicare Physician Fee Schedule conversion factor (H.R. 6683, Preserving Seniors Access to Physicians Act)
Duration: March 10, 2021
to
present
General Issues: Health Issues , Medicare/Medicaid , Taxation/Internal Revenue Code
Spending: about $2,157,431 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Patrick Velliky
Legislative Director, Congressman James B. Renacci
Legislative Assistant, Congressman James B. Renacci
Deputy Legislative Director, Senator Arlen Specter
Legislative Director, Congressman James B. Renacci (Feb 2014 - Sept 2015)
Legislative Assistant, Congressman James B. Renacci (Jan 2011 - Oct 2011)
Deputy Legislative Director, Senator Arlen Specter (April 2019 - Jan 2011)
Legislative Director, Congressman James B. Renacci (Feb 2014 - Sept 2015)
Legislative Assistant, Congressman James B. Renacci (Jan 2011 - Oct 2011)
Deputy Legislative Director, Senator Arlen Specter (April 2009 - Jan 2011)
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on April 18.
Original Filing: 301553108.xml
Lobbying Issues
Oversight of No Surprises Act implementation; clinician behavioral health and well-being, including funding of grant programs authorized by the Dr. Lorna Breen Provider Protection Act; S.3679/H.R.7153 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Inflationary adjustment for physician fee schedule (H.R. 2474, Strengthening Medicare for Patients and Providers Act); Reduce proposed CY2024 cut to Medicare Physician Fee Schedule conversion factor by eliminating the proposed G2211 add-on code; Reduce or eliminate proposed cut to CY2024 Medicare Physician Fee Schedule conversion factor (H.R. 6683, Preserving Seniors Access to Physicians Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Jan. 16.
Original Filing: 301524980.xml
Lobbying Issues
Oversight of No Surprises Act implementation; clinician behavioral health and well-being, including funding of grant programs authorized by the Dr. Lorna Breen Provider Protection Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Inflationary adjustment for physician fee schedule (H.R. 2474, Strengthening Medicare for Patients and Providers Act); Reduce proposed CY2024 cut to Medicare Physician Fee Schedule conversion factor by eliminating the proposed G2211 add-on code; Reduce or eliminate proposed cut to CY2024 Medicare Physician Fee Schedule conversion factor (H.R. 6683, Preserving Seniors Access to Physicians Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Oct. 19, 2023.
Original Filing: 301507271.xml
Lobbying Issues
Oversight of No Surprises Act implementation; clinician behavioral health and well-being, including funding of grant programs authorized by the Dr. Lorna Breen Provider Protection Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Inflationary adjustment for physician fee schedule (H.R. 2474, Strengthening Medicare for Patients and Providers Act); Reduce proposed CY2024 cut to Medicare Physician Fee Schedule conversion factor by eliminating the proposed G2211 add-on code
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on July 17, 2023.
Original Filing: 301477403.xml
Lobbying Issues
Oversight of No Surprises Act implementation; clinician behavioral health and well-being, including funding of grant programs authorized by the Dr. Lorna Breen Provider Protection Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Inflationary adjustment for physician fee schedule (H.R. 2474, Strengthening Medicare for Patients and Providers Act); extend Medicare copay cap for outpatient services performed in ASCs (Outpatient Surgery Quality and Access Act of 2023, H.R. 972/S. 312).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on April 21, 2023.
Original Filing: 301468249.xml
Lobbying Issues
Oversight of No Surprises Act implementation; clinician behavioral health and well-being.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Inflationary adjustment for physician fee schedule; extend Medicare copay cap for outpatient services performed in ASCs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301436889.xml
Lobbying Issues
Continued disbursement of assistance from the Provider Relief Fund; Extension of expiring statutory increases to payments under the Medicare Physician Fee Schedule; Support for implementation of the No Surprises Act in a fair and transparent way; Extension of telehealth flexibility under the PHE after the expiration of the PHE; support for increased clinician access to mental and behavioral health services; support for reducing the incidence of workplace violence against medical professionals
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; improve long term reimbursement environment under the physician fee schedule; Extension of expiring statutory increases to payments under the Medicare Physician Fee Schedule; Extension of telehealth flexibility under the PHE after the expiration of the PHE;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Oct. 21, 2022.
Original Filing: 301420404.xml
Lobbying Issues
Continued disbursement of assistance from the Provider Relief Fund; Extension of expiring statutory increases to payments under the Medicare Physician Fee Schedule; Support for implementation of the No Surprises Act in a fair and transparent way; Extension of telehealth flexibility under the PHE after the expiration of the PHE; support for increased clinician access to mental and behavioral health services; support for reducing the incidence of workplace violence against medical professionals
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; improve long term reimbursement environment under the physician fee schedule;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301396388.xml
Lobbying Issues
Continued disbursement of assistance from the Provider Relief Fund; Extension of expiring statutory increases to payments under the Medicare Physician Fee Schedule; Support for implementation of the No Surprises Act in a fair and transparent way;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; improve long term reimbursement environment under the physician fee schedule;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on April 14, 2022.
Original Filing: 301356162.xml
Lobbying Issues
Federal Support for identifying and addressing health care provider mental and behavioral health (H.R.1667 - Dr. Lorna Breen Health Care Provider Protection Act); Continued disbursement of assistance from the Provider Relief Fund; Support for implementation of the No Surprises Act in a fair and transparent way
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; improve long term reimbursement environment under the physician fee schedule
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301331785.xml
Lobbying Issues
Federal Support for identifying and addressing health care provider mental and behavioral health (H.R.1667 - Dr. Lorna Breen Health Care Provider Protection Act); Continued disbursement of assistance from the Provider Relief Fund; Support for implementation of the No Surprises Act in a fair and transparent way
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extension of the moratorium on the 2% Medicare Sequester (H.R. 1868; S. 748 - Medicare Sequester Relief Act); Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; Medicare reimbursement rates related to the expiration of the 3.75% base rate increase; Waive pay-go rules related to 4% Medicare cut (S.610).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301304327.xml
Lobbying Issues
Federal Support for identifying and addressing health care provider mental and behavioral health (S.610 - Dr. Lorna Breen Health Care Provider Protection Act); Continued disbursement of assistance from the Provider Relief Fund; Support for implementation of the No Surprises Act in a fair and transparent way;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extension of the moratorium on the 2% Medicare Sequester (H.R. 1868; S. 748 - Medicare Sequester Relief Act); Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes; Medicare reimbursement rates related to the expiration of the 3.75% base rate increase; Waive pay-go rules related to 4% Medicare cut.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on July 16, 2021.
Original Filing: 301278115.xml
Lobbying Issues
Federal Support for identifying and addressing health care provider mental and behavioral health (S.610 - Dr. Lorna Breen Health Care Provider Protection Act); Additional funding for the Provider Relief Fund; Support for implementation of the No Surprises Act in a fair and transparent way.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extension of the moratorium on the 2% Medicare Sequester (H.R. 1868; S. 748 - Medicare Sequester Relief Act); Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, ENVISION HEALTHCARE had in-house lobbyists. The report was filed on April 19, 2021.
Original Filing: 301258014.xml
Lobbying Issues
Federal Support for identifying and addressing health care provider mental and behavioral health (S.610 - Dr. Lorna Breen Health Care Provider Protection Act); Federal subsidy of COBRA for loss of coverage due to COVID-19 (H.R. 1319 - American Rescue Plan); Additional funding for the Provider Relief Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extension of the moratorium on the 2% Medicare Sequester (H.R. 1868; S. 748 - Medicare Sequester Relief Act); Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management Codes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
ENVISION HEALTHCARE filed a lobbying registration on April 15, 2021 for in-house lobbying efforts, effective March 10, 2021.
Original Filing: 301253380.xml
Issue(s) they said they’d lobby about: Extension of the moratorium on the 2% Medicare Sequester (H.R. 1868; S. 748 - Medicare Sequester Relief Act)
Federal support for identifying and addressing health care provider mental and behavioral health (S.610 - Dr. Lorna Breen Health Care Provider Protection Act)
Federal subsidy of COBRA for loss of coverage due to COVID-19 (H.R.1319 - American Rescue Plan Act of 2021)
Incentives for states that have not expanded their eligible Medicaid population under the ACA to do so. (H.R.1319 - American Rescue Plan Act of 2021)
Additional federal funding for the Provider Relief Fund
Mitigating significant reductions in reimbursement for providers negatively impacted by changes to Evaluation and Management code .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate